The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Preoperative serum artemin (ARTN) as a predictive biomarker of recurrence following curative resection for hepatocellular carcinoma (HCC).
 
Sophie Feng
No Relationships to Disclose
 
Hao-Wen Sim
Research Funding - Abbvie (Inst); Abbvie (Inst); Abbvie (Inst); Abbvie (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst)
 
Roxana Bucur
No Relationships to Disclose
 
Reenika Aggarwal
No Relationships to Disclose
 
Phillipe Abreu
No Relationships to Disclose
 
Monali Ray
No Relationships to Disclose
 
Michael Herman
No Relationships to Disclose
 
Dangxiao Cheng
No Relationships to Disclose
 
Zhuo Chen
No Relationships to Disclose
 
Wenjiang Zhang
No Relationships to Disclose
 
Paul David Greig
No Relationships to Disclose
 
Alice Chia-chi Wei
Honoraria - Celgene; Celgene; Celgene; Celgene; Ethicon; Ethicon; Ethicon; Ethicon; Ipsen; Ipsen; Ipsen; Ipsen; Shire; Shire; Shire; Shire
Consulting or Advisory Role - Celgene; Celgene; Celgene; Celgene; Ethicon; Ethicon; Ethicon; Ethicon; Ipsen; Ipsen; Ipsen; Ipsen; Shire; Shire; Shire; Shire
Speakers' Bureau - Celgene; Celgene; Celgene; Celgene; Celgene; Celgene; Celgene; Celgene; Shire; Shire; Shire; Shire
Research Funding - Celgene (Inst); Celgene (Inst); Celgene (Inst); Celgene (Inst)
Travel, Accommodations, Expenses - Bayer; Bayer; Bayer; Bayer; Bayer; Bayer; Bayer; Bayer; Shire; Shire; Shire; Shire
Other Relationship - Cancer Care Ontario; Cancer Care Ontario; Cancer Care Ontario; Cancer Care Ontario
 
Carol-Anne Moulton
No Relationships to Disclose
 
Ian M. McGilvray
No Relationships to Disclose
 
Sean P. Cleary
No Relationships to Disclose
 
Steven Gallinger
No Relationships to Disclose
 
Gonzalo Sapisochin
No Relationships to Disclose
 
Jennifer J. Knox
Honoraria - Novartis; Novartis; Novartis; Novartis
Consulting or Advisory Role - Lilly; Lilly; Lilly; Lilly; Merck; Merck; Merck; Merck
Research Funding - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Merck; Merck; Merck; Merck
 
Geoffrey Liu
Honoraria - Abbvie; Abbvie; Abbvie; Abbvie; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Bayer; Bayer; Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Bristol-Myers Squibb; Merck; Merck; Merck; Merck; novartis; novartis; novartis; novartis; pfizer; pfizer; pfizer; pfizer; Roche Canada; Roche Canada; Roche Canada; Roche Canada; Takeda; Takeda; Takeda; Takeda
Consulting or Advisory Role - AstraZeneca/MedImmune; AstraZeneca/MedImmune; AstraZeneca/MedImmune; AstraZeneca/MedImmune; novartis; novartis; novartis; novartis; pfizer; pfizer; pfizer; pfizer; Roche Canada; Roche Canada; Roche Canada; Roche Canada; takeda; takeda; takeda; takeda
Speakers' Bureau - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca
Research Funding - roche (Inst); roche (Inst); roche (Inst); roche (Inst)
 
Eric Xueyu Chen
No Relationships to Disclose